Search

everythinglearnresearchcommunity

for

Search:↓

Collagen XVII is important for skin aging and wound healing.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Squaric acid dibutylester effectively treats alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

A 7-year-old dog with a rare autoimmune disease was euthanized due to severe anemia and poor prognosis.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

No cure exists for alopecia areata, and treatments are personalized.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.